Delivery Order SPE2DR25D2205-SPE2DR26F1V30
- Not listed
- On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $8,186.80 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets in quantities of 8 units. This is a firm fixed-price, non-competitive award with an ultimate completion date of January 15, 2026. The contract represents a purchase order for pharmaceutical products that will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- On January 12, 2026, the Defense Logistics Agency awarded a delivery order valued at $38,284.25 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by January 13, 2026, with performance occurring at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of NURTEC ODT 75 mg tablets (8 count) with a ceiling value of $33,971.19. The contract is scheduled for completion by December 30, 2025, and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $4,184.82 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG Tablet 8S, a migraine treatment medication. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is January 12, 2026, and performance will take place at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $51,160.29 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) on January 15, 2026, with completion scheduled for January 16, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc.,...
- The Defense Logistics Agency awarded a delivery order valued at $7,956.18 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8 count) on January 6, 2026, with completion scheduled for January 7, 2026. This firm fixed-price, competitively awarded delivery order is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed on a full and open basis among qualified...
- On January 15, 2026, the Defense Logistics Agency awarded a delivery order valued at $7,203.28 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is January 16, 2026, and performance will occur at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,930.75 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on December 8, 2025, with a completion date of December 9, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply fulfillment under a non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the federal government's medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units) with a ceiling value of $12,153.68. This is a firm fixed-price delivery order under a non-set-aside competitive procurement, with performance scheduled for completion by November 28, 2025, at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a pharmaceutical supply transaction supporting the federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,327.38 for NURTEC ODT 75 MG tablets (8-count) on December 17, 2025, with completion scheduled for December 18, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1V30Delivery Order
On January 15, 2026, the Defense Logistics Agency awarded a delivery order valued at $80,349.08 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (quantity: 8 units). This firm fixed-price, non-set-aside delivery order is expected to be completed by January 16, 2026, with performance fulfilled at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order represents a task order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The primary IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $80.3k | 1/14/26 |